

Cover Story
FreeNews Analysis
Now that Joseph R. Biden Jr. is inaugurated and safely ensconced in the White House, cancer groups expect him to pick up where he left off as vice president four years ago—pursuing a sober and ambitious agenda for accelerating progress in cancer research.
In Brief


Funding Opportunities
Clinical Roundup


Drugs & Targets


Trending Stories
- Betty Ford and the press conference that changed oncology
- Whither ARPA-H? What can Biden’s agency do that cancer centers can’t?
- Pazdur at FDA-ASCO workshop: Failure to optimize the dose is akin to building a house on quicksand
- FDA’s Lola Fashoyin-Aje: It’s time to increase racial diversity in trials—here’s a draft guidance for how this can be done
- Robert Winn, Rebecca Miksad, Dana Rollison: We must use real-world data and lessons from COVID to improve care, equity in communities we serve
- Gynecology’s deadly surprise: Cancers are frequently missed prior to routine procedures